American Journal of Ophthalmology
Volume 147, Issue 5 , Pages 825-830.e1 , May 2009

Intravitreal Administration of the Anti-Tumor Necrosis Factor Agent Infliximab for Neovascular Age-related Macular Degeneration

  • Panagiotis G. Theodossiadis

      Affiliations

    • Attikon University Hospital, 2nd Department of Ophthalmology, University of Athens, Athens, Greece
    • Corresponding Author InformationInquiries to Panagiotis G. Theodossiadis, 13 Lykiou Street, 10675 Athens, Greece
    • ,
  • Vasilios S. Liarakos

      Affiliations

    • Attikon University Hospital, 2nd Department of Ophthalmology, University of Athens, Athens, Greece
    • ,
  • Petros P. Sfikakis

      Affiliations

    • Laikon Hospital, 1st Department of Propedeutic Medicine, University of Athens, Athens, Greece
    • ,
  • Ioannis A. Vergados

      Affiliations

    • Attikon University Hospital, 2nd Department of Ophthalmology, University of Athens, Athens, Greece
    • ,
  • George P. Theodossiadis

      Affiliations

    • Department of Ophthalmology, Henry Dynan Hospital, Athens, Greece

,Accepted 2 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 See accompanying Editorial on page 761.

PII: S0002-9394(08)00921-5

doi: 10.1016/j.ajo.2008.12.004

American Journal of Ophthalmology
Volume 147, Issue 5 , Pages 825-830.e1 , May 2009

Article Tools

* Image Usage & Resolution